Free Trial

Afya (NASDAQ:AFYA) Price Target Raised to $19.50

Afya logo with Consumer Discretionary background

Afya (NASDAQ:AFYA - Free Report) had its price objective raised by UBS Group from $17.50 to $19.50 in a report published on Thursday,Benzinga reports. UBS Group currently has a neutral rating on the stock.

Other research analysts have also issued research reports about the stock. Wall Street Zen lowered shares of Afya from a "buy" rating to a "hold" rating in a research note on Friday, June 6th. Morgan Stanley cut shares of Afya from an "equal weight" rating to an "underweight" rating and dropped their target price for the company from $19.00 to $17.00 in a research report on Tuesday, March 11th. Three equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company's stock. According to data from MarketBeat, Afya currently has an average rating of "Hold" and an average target price of $17.60.

View Our Latest Stock Analysis on AFYA

Afya Price Performance

NASDAQ:AFYA remained flat at $17.99 during trading hours on Thursday. The company's stock had a trading volume of 95,454 shares, compared to its average volume of 124,699. The firm has a market capitalization of $1.69 billion, a P/E ratio of 14.51, a P/E/G ratio of 0.29 and a beta of 0.60. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.60 and a quick ratio of 1.60. The company's fifty day moving average is $18.39 and its 200 day moving average is $17.15. Afya has a 12-month low of $14.52 and a 12-month high of $19.90.

Hedge Funds Weigh In On Afya

Several institutional investors have recently modified their holdings of the business. Van ECK Associates Corp raised its position in Afya by 41.9% in the 4th quarter. Van ECK Associates Corp now owns 9,677 shares of the company's stock valued at $154,000 after buying an additional 2,856 shares during the last quarter. Teacher Retirement System of Texas acquired a new stake in Afya during the fourth quarter worth approximately $329,000. JPMorgan Chase & Co. boosted its stake in Afya by 2,115.9% in the 4th quarter. JPMorgan Chase & Co. now owns 6,670 shares of the company's stock valued at $106,000 after purchasing an additional 6,369 shares during the period. Wellington Management Group LLP acquired a new position in shares of Afya in the fourth quarter valued at about $829,000. Finally, Renaissance Technologies LLC increased its holdings in shares of Afya by 14.0% during the fourth quarter. Renaissance Technologies LLC now owns 412,000 shares of the company's stock worth $6,543,000 after purchasing an additional 50,700 shares during the period. Institutional investors own 88.02% of the company's stock.

About Afya

(Get Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Further Reading

Analyst Recommendations for Afya (NASDAQ:AFYA)

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines